גאלבוס 50 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

VILDAGLIPTIN 50 MG

Mevcut itibaren:

NOVARTIS PHARMA SERVICES AG

ATC kodu:

A10BH02

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapötik grubu:

VILDAGLIPTIN

Terapötik endikasyonlar:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Yetkilendirme tarihi:

2008-12-01